Microbot Medical Inc. short interest in 2023
In 2023, Microbot Medical Inc.'s disclosed short interest ran from 1.11% of shares outstanding on 13 Jan 2023 to 0.24% on 29 Dec 2023, a change of -0.87 percentage points. The year's high was 1.43% on 15 Aug 2023 and its low 0.24% on 29 Dec 2023, averaging 0.92% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.17 days on 13 Jan 2023. Full history: Microbot Medical Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 1.11% (13 Jan 2023)
- End of year
- 0.24% (29 Dec 2023)
- Change
- -0.87 pp
- High
- 1.43% (15 Aug 2023)
- Low
- 0.24% (29 Dec 2023)
- Average
- 0.92%
- Highest days to cover
- 8.17 (13 Jan 2023)
- SEC filings marked
- 4
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 1.11% | 8.17 | |
| 31 Jan 2023 | 1.13% | 5.19 | |
| 15 Feb 2023 | 1.17% | 4.53 | |
| 28 Feb 2023 | 0.98% | 3.24 | |
| 15 Mar 2023 | 1.02% | 2.45 | |
| 31 Mar 2023 | 1.00% | 3.48 | 10-K filed |
| 14 Apr 2023 | 0.66% | 1.73 | |
| 28 Apr 2023 | 0.58% | 1.02 | |
| 15 May 2023 | 1.00% | 1.00 | |
| 15 Aug 2023 | 1.43% | 1.94 | 10-Q filed, 10-Q filed |
| 31 Aug 2023 | 1.23% | 2.70 | |
| 15 Sep 2023 | 1.40% | 3.22 | |
| 29 Sep 2023 | 1.01% | 1.00 | |
| 13 Oct 2023 | 1.06% | 4.64 | |
| 31 Oct 2023 | 0.70% | 1.00 | |
| 15 Nov 2023 | 0.62% | 1.34 | 10-Q filed |
| 30 Nov 2023 | 0.55% | 1.28 | |
| 15 Dec 2023 | 0.51% | 1.00 | |
| 29 Dec 2023 | 0.24% | 1.00 |
See also: Microbot Medical Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.